"C diff is one of the CDC's top five urgent antibiotic resistance threats. But it's the only one that isn't nationally notifiable."
A third of US active-duty military service members who tested positive for COVID-19 reported new-onset or more difficulty with exercise and daily activities 1 month after diagnosis, but these symptoms diminished to pre-infection levels after 6 to 9 months, according to research presented at this week's Infectious Diseases Society of America (IDSA) ID Week in Washington, DC.
A report published yesterday in Clinical Infectious Diseases describes a new SARS-CoV-2 mutation that confers resistance to the COVID-19 antiviral drug remdesivir in two persistently infected kidney transplant recipients treated with immunosuppressive drugs.
Swiss biopharmaceutical company Ferring Pharmaceuticals announced yesterday that the Food and Drug Administration's (FDA's) Vaccine and Related Biologic Products Advisory Committee (VRBPAC) voted in favor of the company's investigational fecal microbiota transplant (FMT)-based therapy.
The prevalence of Clostridioides difficile infection (CDI) in the United States declined during the COVID-19 pandemic, but inpatient mortality and treatment costs were higher, according to a paper published yesterday in Open Forum Infectious Diseases.
Central line-associated bloodstream infections, ventilator-associated events, and C difficile infections all increased.
A study conducted in a network of urgent care and express care clinics in Iowa found that implementation of cascade reporting was associated with a significant decline in fluoroquinolone prescribing, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology.
"Seeing the numbers really does crystallize the urgency of this issue."
A study by Centers for Disease Control and Prevention researchers found that, despite changes in infection control practices, antibiotic use, and healthcare delivery during the first year of the COVID-19 pandemic, Clostridioides difficile infection rates did not change. The findings were published yesterday in Infection Control & Hospital Epidemiology.
The Minnesota Department of Natural Resources (DNR) yesterday announced that a wild fox in Anoka County near Minneapolis has tested positive for highly pathogenic avian flu, which follows similar detections in Canadian foxes that marked the first known wild mammal infections in North America.